Stay updated on Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial
Sign up to get notified when there's something new on the Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial page.

Latest updates to the Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial page
- Check5 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the underlying clinical trial record.SummaryDifference0.1%

- Check12 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedAdded a new site revision tag 'Revision: v3.5.0' and removed the previous 'Revision: v3.4.3'. The update is a routine version change that does not affect study data or trial details.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 was removed in the page history.SummaryDifference0.1%

- Check76 days agoChange DetectedLatest version adds a Study Status entry dated 2026-02-10 and records revision v3.4.2. It also removes a government funding notice from the page.SummaryDifference0.8%

- Check83 days agoChange DetectedAdded a government funding notice and a new site revision label (v3.4.1); removed the previous revision label (v3.4.0).SummaryDifference0.5%

Stay in the know with updates to Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olezarsen in Hypertriglyceridemia and Atherosclerosis Clinical Trial page.